Utility of diffusion tensor imaging and generalized q-sampling imaging for predicting short-term clinical effect of deep brain stimulation in Parkinson’s disease - Report - MDSpire
Advertisement
Utility of diffusion tensor imaging and generalized q-sampling imaging for predicting short-term clinical effect of deep brain stimulation in Parkinson’s disease
Role of DTI and GQI in Predicting Short-Term DBS Outcomes in Parkinson’s Disease
Overview
This study evaluates whether preoperative diffusion tensor imaging (DTI) and generalized q-sampling imaging (GQI) can non-invasively predict short-term clinical outcomes following deep brain stimulation (DBS) in Parkinson’s disease (PD) patients. Utilizing advanced MRI techniques prior to DBS implantation, the research aims to enhance patient selection and optimize treatment strategies.
Background
Parkinson’s disease is a progressive neurodegenerative disorder characterized by dopaminergic neuron loss in the substantia nigra and resultant motor and non-motor symptoms. Deep brain stimulation targeting the subthalamic nucleus is an established surgical treatment that improves motor dysfunction and may reduce medication needs. Advanced MRI techniques such as DTI and GQI assess microstructural brain integrity and have shown promise in PD diagnosis and symptom correlation. This study uniquely investigates their predictive value for DBS surgical outcomes.
Data Highlights
All MRI examinations were performed 1–3 days before DBS using a 3.0 Tesla MRI with 32-channel head coils. DTI acquisition used 32 diffusion directions with a b-value of 800 s/mm2, repetition time of 3945.52 ms, echo time of 93.70 ms, slice thickness of 2.5 mm, and in-plane resolution of 1.75 mm. The acquisition time was approximately 10 minutes and 50 seconds. DBS targeting was planned using fused MRI and CT images with stereotactic frames, and directional leads were implanted bilaterally.
Key Findings
Preoperative DTI and GQI parameters were assessed to predict clinical outcomes at 3 months post-DBS implantation.
DTI metrics focused on microstructural integrity of dopaminergic pathways relevant to PD motor symptoms.
GQI provided complementary diffusion imaging data to enhance prediction accuracy.
Integration of advanced MRI data with clinical scales (UPDRS, PDQ-39) aimed to forecast motor and quality of life improvements.
Non-invasive imaging biomarkers have potential to improve patient selection and tailor DBS treatment strategies.
Clinical Implications
Incorporating preoperative DTI and GQI imaging into DBS planning may allow clinicians to better predict which PD patients will benefit most from surgery. This approach could optimize patient selection, improve counseling regarding expected outcomes, and potentially reduce unnecessary procedures. Early identification of responders may also facilitate personalized DBS programming and postoperative management.
Conclusion
Preoperative diffusion MRI techniques such as DTI and GQI hold promise as non-invasive tools to forecast short-term clinical outcomes after DBS in Parkinson’s disease. Their use could enhance clinical decision-making and improve therapeutic efficacy.
Aviva Abosch, M.D., Ph.D., a neurosurgeon at Baptist Health Miami Neuroscience Institute, part of Baptist Health Brain and Spine Care, was installed as the Esernia Endowed Chair in Surgical Treatment of Adult Epilepsy and Movement Disorders.